Search for: therapies for

• 27,251 Results (Page 1 of 1,363)
• • Relevance 

    • Relevance
    • Published
    • Price
    Sort by Relevance Published Price

The Market for Cell and Gene Therapy Manufacturing - The Rise of CMOs & CDMOs (2021)

•  Report
• June 2021
• 123 Pages

From

€1186EUR$1,297USD£1,006GBP

Biological Therapies for Cancer: Technologies and Global Markets 2021-2026

•  Report
• September 2021
• 258 Pages

From

€5029EUR$5,500USD£4,268GBP

The Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs)

•  Report
• April 2021
• 140 Pages

From

€3658EUR$4,000USD£3,104GBP

Non-hormonal Therapies for Women's Health Market by Target Indication, Type of Molecule, Purpose of Therapy, Mechanism of Action, Route of Administration, and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

•  Report
• March 2021
• 207 Pages

From

€5028EUR$5,499USD£4,267GBP

Global Market for Gene Therapy 2019 - Product Pipeline, Market Size, & Forecasts

•  Report
• August 2019
• 264 Pages

From

€3653EUR$3,995USD£3,100GBP

Global Market for Cell Therapy & Tissue Engineering 2019

•  Report
• May 2019
• 301 Pages

From

€3653EUR$3,995USD£3,100GBP

Cold Chain Logistics Market for Healthcare: Focus on Cell Therapies, Vaccines, and Human Organs, 2018-2030

•  Report
• September 2018
• 497 Pages

From

€3199EUR$3,499USD£2,715GBP

Proton Therapy Market Outlook, Actual & Potential Market, Actual and Potential Candidate for Proton Therapy, List of Proton Therapy Centers, Start of Treatment, Number of Patients Treated, Specifications & Company Analysis - Global Forecast to 2024

•  Report
• July 2018
• 429 Pages

From

€2185EUR$2,390USD£1,854GBP

Therapies and Diagnostics for Ovarian Cancer: Global Markets to 2022

•  Report
• April 2018
• 168 Pages

From

€2515EUR$2,750USD£2,134GBP

Therapies for Rheumatoid Arthritis: Technologies and Global Markets

•  Report
• July 2016
• 93 Pages

From

€2515EUR$2,750USD£2,134GBP

Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026

•  Report
• August 2016
• 359 Pages

From

€2148EUR$2,349USD£1,823GBP

Car T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2021

•  Clinical Trials
• September 2021
• 60 pages

From

€1463EUR$1,600USD£1,241GBP

€1829EUR$2,000USD£1,552GBP

Car T-Cell Therapy for Non-Hodgkin's Lymphoma - Pipeline Insight, 2021

•  Clinical Trials
• September 2021
• 60 pages

From

€1463EUR$1,600USD£1,241GBP

€1829EUR$2,000USD£1,552GBP

Car T-Cell Therapy for Multiple Myeloma - Pipleine Insight, 2021

•  Clinical Trials
• September 2021
• 60 pages

From

€1463EUR$1,600USD£1,241GBP

€1829EUR$2,000USD£1,552GBP

Global Gene Therapy for CNS Disorders Market 2019-2023

•  Report
• March 2019
• 119 pages

From

€2286EUR$2,500USD£1,940GBP

Outlook for Viral Vector Contract Manufacturing - Gene Therapies, Cell Therapies, and COVID-19 Vaccines

•  Report
• May 2021
• 62 pages

From

€4567EUR$4,995USD£3,876GBP

Drugs For Hormonal Replacement Therapy Global Market Report 2021: COVID-19 Impact and Recovery to 2030

•  Report
• June 2021

From

€4572EUR$5,000USD£3,880GBP

CAR T-Cell Therapy for Multiple Myeloma - Market Insights and Market Forecast - 2030

•  Report
• April 2020
• 200 pages

From

€5084EUR$5,560USD£4,314GBP

€6355EUR$6,950USD£5,393GBP

Drugs For Hormonal Replacement Therapy Global Market Report 2020-30: COVID-19 Impact and Recovery

•  Report
• October 2020

From

€3658EUR$4,000USD£3,104GBP

CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insights and Market Forecast - 2030

•  Report
• April 2020
• 200 pages

From

€5084EUR$5,560USD£4,314GBP

€6355EUR$6,950USD£5,393GBP

• 27,251 Results (Page 1 of 1,363)
• • 1
  • 2
  • 3
  • 